Edgewood Oncology

About:

Edgewood Oncology is promoting a first-in-class therapy for malignancies that are challenging to treat.

Website: https://www.edgewoodoncology.com/

Top Investors: Alta Partners

Description:

Edgewood Oncology is a clinical-stage biotechnology business established to fulfill the potential of BTX-A51 for patients with solid tumors that are genetically specified and hematologic malignancies. Our goal is to create a novel treatment that will prolong and enhance the lives of those with the greatest unmet medical needs.

Total Funding Amount:

$20M

Headquarters Location:

Brookline, Massachusetts, United States

Founded Date:

2023-01-01

Contact Email:

info(AT)edgewoodonc.com

Founders:

David N. Cook

Number of Employees:

1-10

Last Funding Date:

2024-03-25

IPO Status:

Private

Industries:

© 2025 bioDAO.ai